Foundayo Dosage: How Oral GLP-1 Dose Escalation Works

Foundayo (orforglipron) is an oral GLP-1 receptor agonist approved by the FDA for weight management in adults. Like other medications in its class, it isn’t started at full strength. 

Instead, it follows a gradual dose-escalation schedule that starts low and increases over several months. This approach, called titration, is used with many GLP-1 medications. In this article, you’ll find the complete Foundayo dosage schedule, the clinical reasoning behind starting slow, and why every dose change should be guided by a licensed provider.

‍

What Is Foundayo (Orforglipron)?

Foundayo is the brand name for orforglipron, an oral GLP-1 receptor agonist approved by the FDA for weight management in adults with obesity or who are overweight with at least one weight-related health condition. It’s meant to be used alongside a reduced-calorie diet and increased physical activity.

Foundayo is a once-daily pill (not an injection) that can be taken at any time of day, with or without food, and with no water restrictions. So what does the medication actually do? 

A GLP-1 receptor agonist activates GLP-1 receptors. GLP-1 is a hormone involved in regulating appetite and caloric intake. Foundayo also delays gastric emptying (the rate at which food leaves your stomach) and decreases food intake, an effect that is likely mediated by decreased appetite. 

Since it’s a prescription medication, however, a licensed provider always determines your specific orforglipron dosage. If you’re unsure of your next step, a great starting point is our BMI calculator to better understand your BMI before discussing treatment eligibility with a licensed provider. 

‍

The Full Foundayo Dosage Schedule

The Foundayo dose escalation schedule is set by the FDA-approved prescribing information, and it follows a predictable, step-by-step path:

In total, Foundayo comes in six tablet strengths — 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, and 17.2 mg. 

It’s worth noting that not everyone reaches the maximum dose. After the 5.5 mg dose, the prescribing information allows the dose to be increased to the next level, 9 mg, 14.5 mg, or 17.2 mg, after at least 30 days on the current dose, based on treatment response and tolerability. Your prescriber ultimately determines whether further dose escalation is appropriate. 

‍

How to Take Foundayo Correctly

• Swallow tablets whole; do not break, crush, or chew them.
• Take one tablet once daily, at any time of day.
• You can take it with or without food, and there are no water restrictions.
• Store tablets in their original bottle and carton at room temperature (68℉-77℉ / 20℃-25℃), since the tablets are light-sensitive.

If you miss a dose, take it as soon as you remember. Do not double up your next dose. If you miss 7 or more consecutive doses, the prescribing information directs restarting dose escalation at a lower dose to reduce the risk of gastrointestinal side effects; contact your provider for guidance on how to restart.

‍

Why GLP-1 Medications Always Start Low: The Reason Behind Dose Escalation

Building up slowly may feel like it’s holding back your results, but oral GLP-1 titration exists for various reasons, such as:

1. Managing GI side effects: GLP-1 receptor agonists may delay gastric emptying and can cause gastrointestinal adverse reactions such as nausea, vomiting, and diarrhea. Foundayo’s dose-escalation schedule is intended to reduce the risk of gastrointestinal adverse reactions. 
2. Treatment tolerability: At the end of the day, rushing the process may amplify side effects without meaningfully improving your results. Gradual dose escalation allows tolerability to be assessed before moving to higher dose levels. 
3. Individual response: Different people respond differently. After reaching 5.5 mg, further dose increases are based on treatment response and tolerability.

In short, the titration schedule is part of Foundayo’s FDA-approved dosing protocol, and gradual dose escalation is also used with many other GLP-1 medications, not just Foundayo. If you’re curious to learn more, read our more in-depth article about how GLP-1 medications work.

‍

Who Decides When to Increase Your Foundayo Dose?

Your licensed healthcare provider decides your Foundayo dosage. When deciding whether to advance your dose, a provider weighs how well you’re tolerating the current dose, your treatment response, and your overall health.

If results feel slow, it may be tempting to increase your dose faster than prescribed. But advancing too quickly may increase the risk of GI side effects severe enough to cause dehydration, which can in turn affect kidney function. Dose changes should be made with guidance from a licensed healthcare provider, not on your own.

A provider may also adjust the standard schedule in certain situations. For example, strong CYP3A4 inhibitors, such as clarithromycin, can increase Foundayo exposure; when Foundayo is used with a strong CYP3A4 inhibitor, its maximum recommended dose is 9 mg once daily. Thus, Foundayo should be avoided with strong CYP3A4 inhibitors that also inhibit OATP1B. Foundayo is not recommended for people with severe hepatic impairment, while no dosage modification is recommended for mild or moderate hepatic impairment. Always make sure to share a complete list of your medications and supplements with your provider before starting.

‍

Questions to Ask Your Provider About Foundayo Dosing

These questions may help make your conversation with your provider more productive:

• Based on my health history and current medications, is there anything that might affect how my dose is adjusted?
• How will we know when I’m ready to move to the next dose level?
• Which side effects should prompt me to contact you before my next check-in?
• Is there a dose level where you’d expect to see meaningful results, or does that vary from person to person?
• What should I do if I miss several doses in a row?

‍

Foundayo Dosage Compared to Injectable GLP-1 Titration

If you’ve researched injectable GLP-1 medications, the titration concept will feel familiar. 

Gradual dose escalation is used with many GLP-1 receptor agonists, not something specific to Foundayo. Injectable semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) also gradually increase the dose over time. 

The main difference between Foundayo and injectable GLP-1 medications is the routine. Foundayo is a once-daily oral pill with no food or water timing restrictions. Meanwhile, injectable GLP-1s are typically once-weekly subcutaneous injections. But ultimately, the right option depends on your clinical situation.

Either way, both approaches require professional oversight. Whether oral or injectable, GLP-1 dosing should never be self-managed. 

Eden connects you with a licensed provider who can review your health history, determine whether an oral or injectable option is appropriate, and provide treatment guidance. To see what that experience looks like from start to finish, read GLP-1 Support Your Lifestyle: What to Expect From Care. Alternatively, you can get started today with a brief online intake.

‍

Safety Considerations and When to Contact Your Provider

Contact your provider if you experience:

• Persistent or severe nausea, vomiting, or diarrhea. Gastrointestinal side effects can occur during dose escalation, and dehydration from these symptoms may affect kidney function. 
• Severe abdominal pain. This may be a sign of pancreatitis (inflammation of the pancreas). Stop taking Foundayo and contact a provider right away.
• Signs of low blood sugar, such as dizziness, sweating, confusion, shakiness, or a fast heartbeat, especially if you also take insulin or a sulfonylurea.
• A gap of 7 or more consecutive doses. The prescribing information directs restarting dose escalation at a lower dose; contact your provider for guidance. 
• New prescriptions may interact with Foundayo and require a dose adjustment or avoidance.

Foundayo also carries a boxed warning about the risk of thyroid tumors, so make sure to tell your provider about any personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) before starting.

This isn’t a complete list of side effects; learn more about side effects here. And always make sure to review the full prescribing information and talk with your provider for guidance specific to you. If you’re ever unsure whether a symptom or situation warrants a call, it never hurts to reach out and ask.